ESRX trying to make the case that "clinically equivalent" is all that matters in medicine. Of course that is all they have and know full well that a Chevy Cobalt is a car just like a BMW7 but they are far from equivalent. They have rolled the dice on this and are going to lose. They are simply a distributor and cannot control the principals or the market.
since 2001 I've said that airport might as well be in Somalia. there is no security there whatsoever and all the employees do as they please.
only a few days left now till the brakes begin to be applied to Hussein the anti-American communist.....hehehhe.....he'll get nothing in his last two years and will likely trash dim hopes for '16 with his narcissistic arrogance.
you mean the "communist health care act" don't you? the one where the state and its agents pick who lives and dies, wins and loses.
if we list the Dims record, it will choke off this website server.
uhh....look closely, its 87% DISAPPROVAL.
ivan....I would not reject the idea out of hand. only saying there is quite a way to go with ACHN trials. there would have to be a clear improvement pretty much across all variants and the price would have to be right. On the other hand, sometimes the best offense is defense and that means keeping it out of the hands of others.
I could not agree more. ESRX blocked out GILD cuz they KNEW that, given a choice, patients and docs would take Harvoni. ESRX is not making much on Harvoni cuz the reimburse from the carriers is lower by % and they are #$%$. So they are concocting this #$%$ about ABBV being 'just as good' and ABBV needs their support cuz their product is NOT 'just as good'. Its all a colluded bunch of BS.
how much would you pay for a company whose product was "perhaps" slightly better than yours in 'certain situations'. ...and is a long way from an approval. Not much IMO save for the potential need to take them out as a defense of market share.
sure but its just fine for Al Sharpton to be husseins 'race' advisor when he owes over $4million in taxes.
BMO Capital: the label states........the only patient population eligible for a ribavirin free regimen is GT1B non-cirrhotic which is 12 weeks. For all other populations Viekira PLUS ribavirin is indicated.
those guys don't short companies that are growing, well managed and making lots of cash....they're not stupid.
ESRX laid off 400 people in Nov due to loss of clients. Their CFO quit to 'pursue other interests' Dec 16th...she was from Walmart and was on the job less than a year. Do ya think maybe she didn't like the idea of screwing the patients with an inferior product. Walmart provides value. ESRX, not so much.
what are you even talking about:
1. they lost so many clients in 2014, they laid off 400 employees in November
2. after less than a year on the job, their CFO just quit with no reason..she had come from Walmart
3. I have not seen a single upgrade in the last two days for this company.
yes they did and I couldn't be happier they are getting an A$$whippin.....the fact that everyone is getting hammered indicates there is now a fundamental problem in this market and that problem is letting a DISTRIBUTOR dictate what the principals have to do......it will not last.....the distributor will be spanked by all the principals.